Shah Gaurav, CEO of Rocket Pharmaceuticals ($RCKT), made one open market purchase of shares in the last year, totaling $102 thousand, with the most recent on April 10, 2025. This ranks 2,150th among nearly 5,000 insiders, below the average $1.5 million across 3.3 buys. He sold shares five times for $118 thousand total, most recently on February 18, 2026, ranking 9,335th out of over 11,600 insiders, far under the $8.6 million average over 6.4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 5990 | $3.34 | 1,452,293.0000 | 111,571,136 | 0.41% | 0.01% |
| Feb. 13, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 12279 | $3.31 | 1,458,283.0000 | 111,571,136 | 0.83% | 0.01% |
| Feb. 11, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | A | Stock Option (Right to Buy) | 870648 | $0.00 | 870,648.0000 | 111,571,136 | 9999.99% | 0.78% |
| Feb. 11, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | A | Common Stock | 286028 | $0.00 | 1,470,562.0000 | 111,571,136 | 24.15% | 0.26% |
| Nov. 18, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 6276 | $2.98 | 1,184,534.0000 | 111,571,136 | 0.53% | 0.01% |
| Aug. 18, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | F | Common Stock | 2234 | $3.05 | 1,190,810.0000 | 94,807,773 | 0.19% | 0.00% |
| May 20, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 2253 | $6.45 | 1,193,044.0000 | 94,807,773 | 0.19% | 0.00% |
| May 16, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 3621 | $6.53 | 1,195,297.0000 | 94,807,773 | 0.30% | 0.00% |
| April 10, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | P | Common Stock | 20000 | $5.08 | 1,198,918.0000 | 94,807,773 | 1.70% | 0.02% |
| Feb. 21, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 16303 | $10.58 | 1,178,918.0000 | 94,807,773 | 1.36% | 0.02% |
| Feb. 11, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | A | Stock Option (Right to Buy) | 243345 | $0.00 | 243,345.0000 | 94,807,773 | 9999.99% | 0.26% |
| Feb. 11, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | A | Common Stock | 81655 | $0.00 | 1,195,221.0000 | 94,807,773 | 7.33% | 0.09% |
| Nov. 21, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 11091 | $13.05 | 1,113,566.0000 | 94,158,491 | 0.99% | 0.01% |
| Aug. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 9650 | $18.50 | 1,124,657.0000 | 84,009,004 | 0.85% | 0.01% |
| May 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | M | Restricted Stock Units | 7979 | $0.00 | 23,940.0000 | 84,009,004 | 25.00% | 0.01% |
| May 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | M | Restricted Stock Units | 9683 | $0.00 | 67,785.0000 | 84,009,004 | 12.50% | 0.01% |
| Feb. 14, 2022 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | J | Restricted Stock Units | 23940 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2023 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | J | Restricted Stock Units | 67785 | $0.00 | 0.0000 | 68,148,925 | 100.00% | 0.10% |
| Feb. 14, 2023 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | J | Common Stock | 67785 | $0.00 | 1,144,097.0000 | 68,148,925 | 6.30% | 0.10% |
| May 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 9790 | $23.35 | 1,134,307.0000 | 84,009,004 | 0.86% | 0.01% |
| May 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | M | Common Stock | 9683 | $0.00 | 1,052,372.0000 | 84,009,004 | 0.93% | 0.01% |
| May 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | M | Common Stock | 7979 | $0.00 | 1,042,689.0000 | 84,009,004 | 0.77% | 0.01% |
| Feb. 14, 2022 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | J | Common Stock | 23940 | $0.00 | 1,076,312.0000 | 0 | 2.27% | 0.00% |
| Feb. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | A | Common Stock | 66577 | $0.00 | 1,027,577.0000 | 84,009,004 | 6.93% | 0.08% |
| Feb. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | S | Common Stock | 20272 | $29.84 | 961,000.0000 | 84,009,004 | 2.07% | 0.02% |
| Feb. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | A | Stock Option (Right to Buy) | 196336 | $0.00 | 196,336.0000 | 84,009,004 | 9999.99% | 0.23% |
| Feb. 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | M | Restricted Stock Units | 38849 | $0.00 | 77,468.0000 | 84,009,004 | 33.40% | 0.05% |
| Feb. 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | M | Common Stock | 46828 | $0.00 | 981,272.0000 | 84,009,004 | 4.55% | 0.06% |
| Feb. 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Shah Gaurav | CEO | M | Restricted Stock Units | 7979 | $0.00 | 31,919.0000 | 84,009,004 | 20.00% | 0.01% |